These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12003375)
1. Biological modifier therapy for the treatment of rheumatoid arthritis. Jenkins JK; Hardy KJ Am J Med Sci; 2002 Apr; 323(4):197-205. PubMed ID: 12003375 [TBL] [Abstract][Full Text] [Related]
2. [New drugs and treatment strategies for rheumatoid arthritis]. Fantini F Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of anakinra in bone: comparison to other biologics. Paget SA Adv Ther; 2002; 19(1):27-39. PubMed ID: 12008859 [TBL] [Abstract][Full Text] [Related]
5. Role of biological agents in immune-mediated inflammatory diseases. Efthimiou P; Markenson JA South Med J; 2005 Feb; 98(2):192-204. PubMed ID: 15759950 [TBL] [Abstract][Full Text] [Related]
6. The impact of new biologicals in the treatment of rheumatoid arthritis. Weaver AL Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii17-iii23. PubMed ID: 15150428 [TBL] [Abstract][Full Text] [Related]
7. Overview of radiologic efficacy of new treatments. van der Heijde DM Rheum Dis Clin North Am; 2004 May; 30(2):285-93, vi. PubMed ID: 15172041 [TBL] [Abstract][Full Text] [Related]
8. Interpreting radiographic data in rheumatoid arthritis. Ory PA Ann Rheum Dis; 2003 Jul; 62(7):597-604. PubMed ID: 12810418 [TBL] [Abstract][Full Text] [Related]
9. Tides of inflammation: impact of biologics. St Clair EW J Rheumatol Suppl; 2002 Sep; 65():22-6. PubMed ID: 12236618 [TBL] [Abstract][Full Text] [Related]
10. Optimizing outcomes in rheumatoid arthritis. Small RE; Schuna A J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S16-7. PubMed ID: 14626516 [TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of rheumatoid arthritis: old versus new therapies. Saravanan V; Hamilton J Expert Opin Pharmacother; 2002 Jul; 3(7):845-56. PubMed ID: 12083985 [TBL] [Abstract][Full Text] [Related]
15. [Biological agents for therapy of rheumatoid arthritis--overview]. Takeuchi T Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409 [No Abstract] [Full Text] [Related]
16. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis. Cohen SB Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046 [TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis by TNF-blocking agents. Graninger W; Smolen J Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849 [TBL] [Abstract][Full Text] [Related]
18. [New perspectives in the treatment of rheumatoid arthritis]. Martín Alcalde E; Cantero Blanco S; Sánchez García FJ; Gómez Castillo JJ Farm Hosp; 2003; 27(6):360-70. PubMed ID: 14974882 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment of rheumatoid arthritis. Strand V Clin Cornerstone; 1999; 2(2):38-50. PubMed ID: 10689543 [TBL] [Abstract][Full Text] [Related]
20. Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifier. Fleischmann RM Clin Ther; 1999 Sep; 21(9):1429-42; discussion 1427-8. PubMed ID: 10509842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]